Uni-Bio Science Group Limited
UNBSF
$0.00
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.88M | 19.94M | 17.97M | 17.91M | 17.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.88M | 19.94M | 17.97M | 17.91M | 17.50M |
| Cost of Revenue | 3.60M | 3.61M | 3.14M | 3.13M | 2.75M |
| Gross Profit | 16.28M | 16.33M | 14.82M | 14.78M | 14.75M |
| SG&A Expenses | 10.37M | 10.40M | 11.04M | 11.01M | 9.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -53.00K | -53.20K | -171.80K | -171.30K | -183.00K |
| Total Operating Expenses | 14.79M | 14.83M | 16.03M | 15.98M | 12.91M |
| Operating Income | 5.09M | 5.10M | 1.94M | 1.93M | 4.59M |
| Income Before Tax | 5.04M | 5.05M | 1.26M | 1.26M | 4.58M |
| Income Tax Expenses | 172.60K | 173.10K | 272.40K | 271.50K | 266.10K |
| Earnings from Continuing Operations | 4.87M | 4.88M | 989.90K | 986.80K | 4.31M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.87M | 4.88M | 989.90K | 986.80K | 4.31M |
| EBIT | 5.09M | 5.10M | 1.94M | 1.93M | 4.59M |
| EBITDA | 5.70M | 5.71M | 2.19M | 2.18M | 5.13M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 5.97B | 5.97B | 6.12B | 6.12B | 6.16B |
| Average Diluted Shares Outstanding | 5.97B | 5.97B | 6.12B | 6.12B | 6.16B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |